Ground Breaking Medication Free Guidelines Published for Treatment of Depression
TMS is truly a paradigm shift in psychiatry for the first time ever,people can walk away well not just better! ...
Thursday, June 1, 2023
ADVERTISEMENT
Tag: medication
Vodafone: Mobile technology innovation protects elderly people living in own homes
Elderly people living in their own homes have access to an innovative new system to improve their safety and independence, ...
HaH partnership with Paxman coolers prevents unnecessary hair loss
The Paxman scalp cooler is the world leading hair loss prevention system for chemotherapy patients. Healthcare at Home has partnered ...
Depression in Pregnancy: New study shows preferences for therapy over medication
The preliminary study, led by Cynthia L. Battle, PHD, of the Warren Alpert Medical School of Brown University, Butler Hospital, ...
Sanofi announces positive phase 3 results for investigational new insulin U300
These results are from EDITION I and EDITION II respectively and are part of the EDITION Phase 3 clinical program ...
World Federation of Hemophilia marks historic anniversary for the Global Bleeding Disorders Community
Fifty years ago, on June 25, 1963, the WFH held its first meeting in Copenhagen, Denmark. Working with leaders from ...
1 million diabetic patients in Dutch uncertainty
Somewhat However, the lives of people with diabetes has everything except security for the future. Despite the treatment of diabetes may still ...
New trial results support treatment with Inspra (eplerenone) within first 24 hours of symptoms, in addition to standard therapy, in patients with acute STEMI without heart failure.
Pfizer Inc. (NYSE: PFE) today announced results from the REMINDER trial showing statistically significant risk reductions in the primary composite ...
Pfizer’s BOSULIF® (bosutinib) Receives Conditional Marketing Authorization From The European Commission
Pfizer Inc. announced today that the European Commission (EC) has granted conditional marketing authorization for BOSULIF® (bosutinib) in the European ...
GlaxoSmithKline announces start of phase III study of Benlysta® (belimumab ) in patients with vasculitis
GlaxoSmithKline plc (GSK) today announced the start of a Phase III study to evaluate Benlysta® (belimumab) in patients with ANCA (Anti-neutrophil Cytoplasmic ...
Navigating the Public and Private Healthcare Systems in South Africa
Access to quality healthcare is a fundamental right for every individual, and in South Africa, there are two primary healthcare...
Read more
PressCenter.com is state-of-the-art Press Release Distribution Platform. PressCenter.com send and track your Press Release using our industry-leading global Media Contacts Database of a million contacts. Your Press Release will reach business news editors and journalists, in targeted sectors and territories or worldwide.